184 related articles for article (PubMed ID: 31634279)
1. Rate of Initial Hearing Loss During Early Observation Predicts Time to Non-Serviceable Hearing in Patients With Conservatively Managed Sporadic Vestibular Schwannoma.
Carlson ML; Dowling EM; Lohse CM; O'Connell BP; Driscoll CLW; Haynes DS; Link MJ; Hunter JB
Otol Neurotol; 2019 Dec; 40(10):e1012-e1017. PubMed ID: 31634279
[TBL] [Abstract][Full Text] [Related]
2. Hearing Outcomes in Conservatively Managed Vestibular Schwannoma Patients With Serviceable Hearing.
Hunter JB; Dowling EM; Lohse CM; O'Connell BP; Tombers NM; Lees KA; Thompson RS; Haynes DS; Carlson ML
Otol Neurotol; 2018 Sep; 39(8):e704-e711. PubMed ID: 30036205
[TBL] [Abstract][Full Text] [Related]
3. Durability of Hearing Preservation Following Microsurgical Resection of Vestibular Schwannoma.
Dowling EM; Patel NS; Lohse CM; Driscoll CLW; Neff BA; Van Gompel JJ; Link MJ; Carlson ML
Otol Neurotol; 2019 Dec; 40(10):1363-1372. PubMed ID: 31725593
[TBL] [Abstract][Full Text] [Related]
4. The Influence of Vestibular Schwannoma Tumor Volume and Growth on Hearing Loss.
Patel NS; Huang AE; Dowling EM; Lees KA; Tombers NM; Lohse CM; Marinelli JP; Van Gompel JJ; Neff BA; Driscoll CLW; Link MJ; Carlson ML
Otolaryngol Head Neck Surg; 2020 Apr; 162(4):530-537. PubMed ID: 31986971
[TBL] [Abstract][Full Text] [Related]
5. Hearing preservation in patients with vestibular schwannoma treated with Gamma Knife surgery.
Baschnagel AM; Chen PY; Bojrab D; Pieper D; Kartush J; Didyuk O; Naumann IC; Maitz A; Grills IS
J Neurosurg; 2013 Mar; 118(3):571-8. PubMed ID: 23216466
[TBL] [Abstract][Full Text] [Related]
6. Consequences to hearing during the conservative management of vestibular schwannomas.
Walsh RM; Bath AP; Bance ML; Keller A; Rutka JA
Laryngoscope; 2000 Feb; 110(2 Pt 1):250-5. PubMed ID: 10680925
[TBL] [Abstract][Full Text] [Related]
7. Hearing preservation after middle fossa vestibular schwannoma removal: are the results durable?
Quist TS; Givens DJ; Gurgel RK; Chamoun R; Shelton C
Otolaryngol Head Neck Surg; 2015 Apr; 152(4):706-11. PubMed ID: 25628370
[TBL] [Abstract][Full Text] [Related]
8. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on Hearing Preservation Outcomes in Patients With Sporadic Vestibular Schwannomas.
Carlson ML; Vivas EX; McCracken DJ; Sweeney AD; Neff BA; Shepard NT; Olson JJ
Neurosurgery; 2018 Feb; 82(2):E35-E39. PubMed ID: 29309683
[TBL] [Abstract][Full Text] [Related]
9. Degree of preoperative hearing loss predicts time to early mobilization following vestibular schwannoma microsurgery.
Macielak RJ; Barnes JH; Van Gompel JJ; Neff BA; Link MJ; Driscoll CL; Carlson ML; Patel NS
Am J Otolaryngol; 2021; 42(6):103073. PubMed ID: 33915514
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic radiosurgery for vestibular schwannomas: average 10-year follow-up results focusing on long-term hearing preservation.
Watanabe S; Yamamoto M; Kawabe T; Koiso T; Yamamoto T; Matsumura A; Kasuya H
J Neurosurg; 2016 Dec; 125(Suppl 1):64-72. PubMed ID: 27903183
[TBL] [Abstract][Full Text] [Related]
11. Long-term hearing outcome after retrosigmoid removal of vestibular schwannoma.
Nakamizo A; Mori M; Inoue D; Amano T; Mizoguchi M; Yoshimoto K; Sasaki T
Neurol Med Chir (Tokyo); 2013; 53(10):688-94. PubMed ID: 24077269
[TBL] [Abstract][Full Text] [Related]
12. Presbycusis and Hearing Preservation in Observed Vestibular Schwannomas.
Brennan JR; Sharma R; Lindquist NR; Cass ND; Krishnapura SG; Kloosterman N; Perkins E; Bennett ML; O'Malley MR; Haynes DS; Tawfik KO
Otol Neurotol; 2023 Sep; 44(8):817-821. PubMed ID: 37442597
[TBL] [Abstract][Full Text] [Related]
13. Progression of Hearing Loss in Observed Non-Growing Vestibular Schwannoma.
Luryi AL; Babu S; Bojrab DI; Kveton JF; Schutt CA
Otol Neurotol; 2022 Aug; 43(7):e767-e772. PubMed ID: 35763454
[TBL] [Abstract][Full Text] [Related]
14. Fractionated Proton Radiation Therapy and Hearing Preservation for Vestibular Schwannoma: Preliminary Analysis of a Prospective Phase 2 Clinical Trial.
Saraf A; Pike LRG; Franck KH; Horick NK; Yeap BY; Fullerton BC; Wang IS; Abazeed ME; McKenna MJ; Mehan WA; Plotkin SR; Loeffler JS; Shih HA
Neurosurgery; 2022 May; 90(5):506-514. PubMed ID: 35229827
[TBL] [Abstract][Full Text] [Related]
15. Long-term hearing outcomes following stereotactic radiosurgery for vestibular schwannoma: patterns of hearing loss and variables influencing audiometric decline.
Carlson ML; Jacob JT; Pollock BE; Neff BA; Tombers NM; Driscoll CL; Link MJ
J Neurosurg; 2013 Mar; 118(3):579-87. PubMed ID: 23101446
[TBL] [Abstract][Full Text] [Related]
16. Predicting Hearing Outcomes in Conservatively Managed Vestibular Schwannoma Patients Utilizing Magnetic Resonance Imaging.
Selleck AM; Rodriguez JD; Brown KD
Otol Neurotol; 2021 Feb; 42(2):306-311. PubMed ID: 33290358
[TBL] [Abstract][Full Text] [Related]
17. Hearing loss and volumetric growth rate in untreated vestibular schwannoma.
Gurewitz J; Schnurman Z; Nakamura A; Navarro RE; Patel DN; McMenomey SO; Roland JT; Golfinos JG; Kondziolka D
J Neurosurg; 2022 Mar; 136(3):768-775. PubMed ID: 34416729
[TBL] [Abstract][Full Text] [Related]
18. Fractionated stereotactic radiation therapy for vestibular schwannomas: Dosimetric factors predictive of hearing outcomes.
Bennion NR; Nowak RK; Lyden ER; Thompson RB; Li S; Lin C
Pract Radiat Oncol; 2016; 6(5):e155-e162. PubMed ID: 26961715
[TBL] [Abstract][Full Text] [Related]
19. Useful hearing preservation is improved in vestibular schwannoma patients who undergo stereotactic radiosurgery before further hearing deterioration ensues.
Ogino A; Long H; Johnson S; Faramand A; Niranjan A; Flickinger JC; Lunsford LD; Kano H
J Neurooncol; 2021 May; 152(3):559-566. PubMed ID: 33733428
[TBL] [Abstract][Full Text] [Related]
20. Matched Comparison of Hearing Outcomes in Patients With Vestibular Schwannoma Treated With Stereotactic Radiosurgery or Observation.
Schnurman Z; Gurewitz J; Smouha E; McMenomey SO; Roland JT; Golfinos JG; Kondziolka D
Neurosurgery; 2022 Oct; 91(4):641-647. PubMed ID: 36001782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
